Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
P49593
UPID:
PPM1F_HUMAN
Alternative names:
Ca(2+)/calmodulin-dependent protein kinase phosphatase; Partner of PIX 2; Protein fem-2 homolog
Alternative UPACC:
P49593; A8K6G3; B7Z2C3; Q96PM2
Background:
Protein phosphatase 1F, also known as Ca(2+)/calmodulin-dependent protein kinase phosphatase, Partner of PIX 2, and Protein fem-2 homolog, plays a crucial role in cellular signaling pathways. It dephosphorylates and deactivates CaM-kinase II, IV, and I, which are activated upon phosphorylation, thereby regulating calcium signaling and promoting apoptosis.
Therapeutic significance:
Understanding the role of Protein phosphatase 1F could open doors to potential therapeutic strategies. Its involvement in calcium signaling and apoptosis highlights its potential as a target in diseases where these processes are dysregulated.